Phase III Study of Botulax® to Treat Post Stroke Upper Limb Spasticity
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 186 participants.
Also called NCT01915459
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 186 participants
- Sponsor
- Hugel
- Registry
-
NCT01915459
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01915459. Randomized; double masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2014-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Phase III Study of Botulax® to Treat Post Stroke Upper Limb Spasticity
- Condition
- Stroke
- Condition
- Spasticity
- Intervention (Biological)
- Botulinum toxin type A(Botulax®)
- Intervention (Biological)
- Botulinum toxin type A(Botox®)
- Lead sponsor
- Hugel
Record details
- Record id
cardio:ct-nct01915459- Content hash
3558bebfba5a59518b4faa1ef62e45c40208ae97d1a5cdb77645e0411c606dbe